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The 'critical contemporary topics' mentioned by Savioli and colleagues [1] are in part outside the scope of these guidelines (e.g., defining endemicity thresholds and groups at risk for preventive chemotherapy for other NTDs) and in part articulated in the 'research gaps' chapter of the guidelines (e.g., alternative anthelminthic medicines or combinations, innovative distribution system to reach adolescent girls). The GDG considered them important areas in which additional evidence should be collected before WHO can issue recommendations. WHO technical units and our collaborating centres are actively working on these topics.
We thank the authors of the review for their attention to the work of WHO and for their broad agreement with the conclusions of this guideline. While we recognise that they have concerns with the widely accepted methods used by WHO to develop evidence-informed guidelines, we nonetheless look forward to working with all of our partners to decrease the global burden of STHs and other neglected tropical diseases.
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